2141 related articles for article (PubMed ID: 14615692)
1. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
2. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
3. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
4. [Insight in schizophrenia: assessment of 31 patients with different scales].
Travers D; Levoyer D; Millet B
Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between insight and self-reported quality of life among shizophrenic patients].
Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
[TBL] [Abstract][Full Text] [Related]
6. Insight correlates in child- and adolescent-onset first episodes of psychosis: results from the CAFEPS study.
Parellada M; Fraguas D; Bombín I; Otero S; Castro-Fornieles J; Baeza I; Gonzalez-Pinto A; Graell M; Soutullo C; Paya B; Arango C
Psychol Med; 2009 Sep; 39(9):1433-45. PubMed ID: 19091160
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis of short-term outcome in the first admission for psychosis].
Verdoux H; Liraud F; Gonzales B; Fournet O; Pauillac P; Assens F; Abalan F; Beaussier JP; Gaussares C; Etchegaray B; Bourgeois M
Encephale; 1999; 25(3):213-20. PubMed ID: 10434146
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
9. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
10. [Long-term impact of the diagnostic announcement on the insight of patients suffering from schizophrenic disorders].
Gastal D; Januel D
Encephale; 2010 Jun; 36(3):195-201. PubMed ID: 20620261
[TBL] [Abstract][Full Text] [Related]
11. [Obesity, alexithymia, psychopathology and binge eating: a comparative study of 40 obese patients and 32 controls].
De Chouly De Lenclave MB; Florequin C; Bailly D
Encephale; 2001; 27(4):343-50. PubMed ID: 11686056
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
13. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
[TBL] [Abstract][Full Text] [Related]
14. [Drug compliance and health locus of control in schizophrenia].
Combes C; Feral F
Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
[TBL] [Abstract][Full Text] [Related]
15. Emotional dysfunction in schizophrenia spectrum psychosis: the role of illness perceptions.
Watson PW; Garety PA; Weinman J; Dunn G; Bebbington PE; Fowler D; Freeman D; Kuipers E
Psychol Med; 2006 Jun; 36(6):761-70. PubMed ID: 16563207
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and correlates of poor medication adherence amongst psychiatric outpatients in southwestern Nigeria.
Adewuya AO; Owoeye OA; Erinfolami AR; Coker AO; Ogun OC; Okewole AO; Dada MU; Eze CN; Bello-Mojeed MA; Akindipe TO; Olagunju AT; Etim E
Gen Hosp Psychiatry; 2009; 31(2):167-74. PubMed ID: 19269538
[TBL] [Abstract][Full Text] [Related]
17. [Relationships between positive or negative early subjective response to antipsychotics and demographic and clinical variables in the group of patients with schizophrenia].
Murawiec S
Psychiatr Pol; 2005; 39(6):1185-98. PubMed ID: 16526184
[TBL] [Abstract][Full Text] [Related]
18. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
[TBL] [Abstract][Full Text] [Related]
19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
20. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
